Find similar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 17780/0518.
Zolmitriptan 2.5mg orodispersible tablets
Zolmitriptan 2.5 mg orodispersible tablets
Zolmitriptan 5 mg orodispersible tablets
1. What Zolmitriptan is and what it is used for
2. What you need to know before you take Zolmitriptan
3. How to take Zolmitriptan
4. Possible side effects
5. How to store Zolmitriptan
6. Contents of the pack and other information
The name of your medicine is Zolmitriptan 2.5 mg orodispersible tablets or Zolmitriptan 5 mg orodispersible tablets (called Zolmitriptan throughout this leaflet).
Zolmitriptan orodispersible tablets contain the active substance zolmitriptan and belongs to a group of medicines called triptans.
Zolmitriptan is used to treat migraine attacks (headaches and nausea).
Migraine symptoms may be caused by swollen blood vessels in the head. Zolmitriptan reduces the widening of these blood vessels. This helps to take away the headache and other symptoms of a migraine attack, such as feeling or being sick (nausea or vomiting) and being sensitive to light and sound.
Zolmitriptan works only when a migraine attack has started. It will not stop you from getting an attack.
Do not take Zolmitriptan if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Zolmitriptan.
Talk to your doctor or pharmacist before taking Zolmitriptan
The use of Buprenorphine together with zolmitriptan can lead to serotonin syndrome, a potentially life-threatening condition (see “Other medicines and Zolmitriptan”).
Zolmitriptan is not recommended for patients under 18 years or over 65.
As with other migraine treatments, using too much Zolmitriptan can cause daily headaches or can make your migraine headaches worse.
Ask your doctor if you think that this is the case for you. You may need to stop taking Zolmitriptan to correct the problem.
Tell your doctor or pharmacist if you are taking or have recently taken or might have taken any other medicines.
In particular, tell your doctor if you are taking any of the following medicines:
Medicines for migraine
Medicines for depression
Other medicines
Some medicines may increase the side effects of zolmitriptan and may sometimes cause very serious reactions. Do not take any other medicines whilst taking zolmitriptan without first talking to your doctor, especially:
You can take Zolmitriptan with or without food. It does not affect the way that Zolmitriptan works.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
It is not known if taking zolmitriptan during pregnancy is harmful.
Therefore it should be used during the pregnancy only if the potential benefit to the mother outweighs the potential risk to the unborn child and no other appropriate treatment option is available.
No data exists on the excretion of zolmitriptan into breast milk. Therefore, as a precautionary measure, breast-feeding should be avoided for 24 hours after treatment.
During a migraine attack your reactions may be slower than usual. Bear this in mind when you drive or use any tools or machines.
Zolmitriptan is unlikely to affect driving or using tools or machines. However, it may make you feel sleepy. Wait to see how Zolmitriptan affects you before you try these activities.
This medicine contains 2.5/5 mg aspartame in each 2.5/5 mg orodispersible tablet. Aspartame is a source of phenylalanine It maybe harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly.
This medicine contains less than 1 mmol sodium (23 mg) per orodispersible tablet, that is to say essentially “sodium-free”.
Always take this medicine exactly as your doctor has told you.
Check with your doctor or pharmacist if you are not sure.
Zolmitriptan is used to treat migraine attacks. Take Zolmitriptan as soon as possible after your migraine headache has started. You can also take it once an attack is underway.
Do not use it to prevent an attack.
Do not use more than the dose prescribed for you.
Adults (aged over 18 years and under 65 years)
The usual starting dose is 2.5 mg of zolmitriptan. If a 2.5 mg dose did not give you enough help with your migraine, tell your doctor. Your doctor may change your treatment and recommend you take a 5mg dose for your next attack.
Occurrence of side effects is more likely with higher doses.
The maximum daily dose is 10mg zolmitriptan.
Special patient groups
Patients aged over 65 years
Zolmitriptan should not be given to patients over 65 years.
Patients with liver problems
If you have liver problems, the recommended maximum daily dose is lowered to 5mg.
Patients with kidney problems
Your dosage can be the same as in adults.
Children and adolescents under 18 years of age
Zolmitriptan should not be given to children or adolescents under 18 years of age.
If after 2 hours after taking Zolmitriptan you still have migraine or migraine returns within 24 hours you can take another tablet Do not take more than 2 doses of Zolmitriptan in a 24-hour period (more than two 2.5 mg or 5 mg doses in a 24-hour period – according to your prescribed dose).
Always wait at least 2 hours between doses.
If the tablets did not give you enough help with your migraine, tell your doctor. Your doctor may change your treatment.
If your condition worsens, seek medical attention.
If you take more tablets than you should or someone accidentally swallows some, contact your doctor or go to the nearest hospital straight away. Take the medicine pack and any remaining tablets with you so that the doctor knows what has been taken.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Some of the symptoms below could be part of the migraine attack itself.
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to1 in 10,000 people):
Common (may affect up to 1 in 10 people):
These side effects are usually mild and go away after a short time.
Uncommon (may affect up to 1 in 100 people):
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the package. The expiry date refers to the last day of that month.
This medicinal product doesn´t require any special temperature storage conditions.
Store in the original inner package (blister) in order to protect from moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
What Zolmitriptan orodispersible tablets contain 2.5 mg orodispersible tablets: The active substance is zolmitriptan 2.5 mg per each tablet.
The other ingredients are: mannitol, cellulose microcrystalline, aspartame, croscarmellose sodium, silica colloidal anhydrous, magnesium stearate, orange powder flavour; (maltodextrine, thickener gum arabic (acacia gum) (E414), vegetable oil, antioxidant butylated hydroxyanisole (BHA) (E320), antioxidant alpha-tocopherol (E307).
5 mg orodispersible tablets: The active substance is zolmitriptan 5mg per each tablet.
The other ingredients are: mannitol, cellulose microcrystalline, aspartame, orange flavour (maltodextrin, acacia gum E414, ascorbic acid E300, butylated hydroxyanisole E320), croscarmellose sodium, silica colloidal anhydrous, magnesium stearate.
2.5 mg orodispersible tablets: White to off-white, round, flat faced bevelled edge uncoated tablet with “2.5”’ debossed on one side and plain on other side.
5 mg orodispersible tablets: White to off white round biconvex uncoated tablets with deep breakline on one side and plain on other side. The tablet can be divided into equal halves.
Size of packing
Zolmitriptan 2.5 mg orodispersible tablets: 2, 3, 6, 7, 10, 12, 14, 18.
Zolmitriptan 5 mg orodispersible tablets: 2, 3, 6, 7, 10, 12, 14, 18.
Not all pack sizes may be marketed.
2.5 mg orodispersible tablets
5 mg orodispersible tablets
This leaflet was last revised in September 2024
61156